{"id":638,"date":"2006-07-26T00:00:00","date_gmt":"2006-08-31T11:17:50","guid":{"rendered":""},"modified":"2022-09-25T21:30:30","modified_gmt":"2022-09-26T01:30:30","slug":"letter-to-industry-canada-re-addition-of-oseltamivir-phosphate-to-schedule-1-to-the-patent-act","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/letter-to-industry-canada-re-addition-of-oseltamivir-phosphate-to-schedule-1-to-the-patent-act\/","title":{"rendered":"Letter to Industry Canada re: Addition of oseltamivir phosphate to Schedule 1 to the Patent Act"},"content":{"rendered":"&#8221;On July 1, 2006 the Departments of Industry and Health published, in Part I of the Canada Gazette, the proposed text of an order to amend Schedule 1 to the Patent Act to add &#8220;oseltamivir phosphate&#8221;, in both capsule form as well as in powder for oral suspension, to the list of patented pharmaceutical products eligible to be exported under compulsory license. The Canadian HIV\/AIDS Legal Network wishes to register its support for the proposed amendment, and to encourage the Governor in Council to make the proposed order without further delay\u2026&#8221;<br \/>\n<!-- Tamiflu, Susan Bincoletto, Joanne Csete --><p class=\"download-link-button\"><a class=\"download-link en\" title=\"Letter to Industry Canada re: Addition of oseltamivir phosphate to Schedule 1 to the Patent Act\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/10692\/?tmstv=1777512105\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184],"class_list":["post-638","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":5,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/638\/revisions"}],"predecessor-version":[{"id":20910,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/638\/revisions\/20910"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=638"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=638"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=638"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}